Form 8-K - Current report:
SEC Accession No. 0001048477-25-000098
Filing Date
2025-08-11
Accepted
2025-08-11 16:02:59
Documents
12
Period of Report
2025-08-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K bmrn-20250805.htm   iXBRL 8-K 22765
  Complete submission text file 0001048477-25-000098.txt   138530

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20250805.xsd EX-101.SCH 1882
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20250805_lab.xml EX-101.LAB 21880
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20250805_pre.xml EX-101.PRE 12603
14 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20250805_htm.xml XML 2712
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 251201916
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)